Crispr Therapeutics shares tumble after significant earnings miss
In a recent series of transactions, Kirk E. Kleiser, a director at Catalyst Bancorp , Inc. (NASDAQ:CLST), acquired a substantial amount of common stock. According to a Form 4 filing with the Securities and Exchange Commission, Kleiser purchased a total of 1,750 shares on June 11, 2025, with a total transaction value of approximately $21,492. The purchase comes as the stock trades near its 52-week high of $12.40, with InvestingPro data showing management has been actively buying back shares.
The purchases were made at prices ranging from $12.235 to $12.2999 per share. These acquisitions were conducted through various ownership structures, including an Individual Retirement Account (IRA), Kleiser Enterprises Corporation, and accounts associated with his spouse. With a market capitalization of $51.32 million and a price-to-book ratio of 0.64, InvestingPro analysis suggests the stock is currently trading below its Fair Value.
Following these transactions, Kleiser’s total direct and indirect holdings in Catalyst Bancorp increased, reflecting his continued confidence in the company’s prospects. As of the latest filing, his total shareholding stands at a significant number, spread across multiple ownership entities. For deeper insights into insider transactions and additional financial metrics, investors can access more exclusive tips and analysis through InvestingPro.
In other recent news, Catalyst Bancorp, Inc. announced the results of its Annual Meeting held on May 20, 2025. During the meeting, shareholders voted on three key proposals. The election of directors Todd A. Kidder and Kirk E. Kleiser for a three-year term was confirmed, with both nominees receiving a majority of the votes. Additionally, shareholders ratified the appointment of HORNE LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, with a significant majority in favor. A non-binding resolution to approve the compensation of the company’s named executive officers was also adopted, receiving substantial support from the voting shareholders. The meeting established a quorum with 3,567,299 shares represented in person or by proxy out of the 4,205,201 eligible shares. All proposals on the agenda were successfully passed by the shareholders, as recorded in the company’s SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.